Veterans' affairs

Second Fisher House Dedicated at the Audie Murphy VA Campus of South Texas VA

Retrieved on: 
Friday, April 5, 2024
Audie Murphy, Veterans' affairs, Partnership, Health, Patient, Audie, House, Fisher House, Amazon Web Services, Road, Hospital, Fisher House Foundation, Navy

San Antonio, Texas, April 05, 2024 (GLOBE NEWSWIRE) -- A second Fisher House was dedicated today at the Audie L. Murphy Memorial Veterans’ Hospital by Executive Director Dr. Julianne Flynn and President of Fisher House Foundation David A. Coker.

Key Points: 
  • San Antonio, Texas, April 05, 2024 (GLOBE NEWSWIRE) -- A second Fisher House was dedicated today at the Audie L. Murphy Memorial Veterans’ Hospital by Executive Director Dr. Julianne Flynn and President of Fisher House Foundation David A. Coker.
  • The new home will double the South Texas VA Health Care System’s capacity to offer a home away from home to the families of Veterans who are inpatients at the Audie Murphy VA Medical Center.
  • Fisher House Foundation is on the Road to 100 Fisher Houses with projects underway in Memphis, Tennessee; Detroit, Michigan; and the 100th Fisher House, which will be in North Chicago, Illinois.
  • The new South Texas VA Fisher House has 16 wheelchair-accessible suites; a spacious kitchen; large communal living, dining, and family rooms; a laundry room; and a shared patio.

DAV Recognizes PRIDE Industries as a Patriot Employer

Retrieved on: 
Thursday, April 4, 2024
DAV, Veterans' affairs, PRIDE, Employment, Government, Talent management, Veteran, ERG, Mentorship, Disability, Disabled American Veterans

Roseville, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- PRIDE Industries, the nation’s leading employer of people with disabilities, has been named a DAV Patriot Employer.

Key Points: 
  • Roseville, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- PRIDE Industries, the nation’s leading employer of people with disabilities, has been named a DAV Patriot Employer.
  • “We are honored by this important acknowledgment,” said Tim Young, Vice President, Talent Management at PRIDE Industries.
  • In addition, PRIDE Industries helps veterans access mentoring and training programs, as well as paid internships.
  • “It is with great pleasure that we recognize PRIDE Industries as a DAV Patriot Employer,” said Ryan Burgos, National Employment Director at DAV.

Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board

Retrieved on: 
Tuesday, April 2, 2024
Citadel, Depression, Department of Defence, National War College, Legislation, Government, Army Command, Veteran, Veterans' affairs, General counsel, Patient, Insomnia, Colonel, TBI, Policy, Senior counsel, University, Anxiety, Military personnel, Military, Traumatic brain injury, OGC, National Security Strategy, Private law, PTSD, Nursing

HOUSTON, TEXAS, April 02, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW), today announced the appointment of former Acting General Counsel to the Department of Veterans Affairs, William (“Bill”) A. Hudson, Jr., to the Company’s Military & Government Advisory Board (“Advisory Board”).

Key Points: 
  • HOUSTON, TEXAS, April 02, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW), today announced the appointment of former Acting General Counsel to the Department of Veterans Affairs, William (“Bill”) A. Hudson, Jr., to the Company’s Military & Government Advisory Board (“Advisory Board”).
  • Nexalin’s Advisory Board provides strategic advice and counsel to support the Company’s advancement of its non-invasive, frequency-based, deep-brain stimulation devices in U.S. military and government agencies.
  • Mr. Hudson is a partner in Tully Rinckey PLLC’s Washington, D.C. office where he focuses his practice on military, security clearance, and federal employment law.
  • Mark White, CEO of Nexalin Technology stated, “We are honored to welcome Col. Bill Hudson to the Military & Government Advisory Board.

Affirmed Housing Celebrates Completion of New Affordable and Supportive Housing Development in San Jose

Retrieved on: 
Monday, April 1, 2024
Health, AMI, Veteran, Veterans' affairs, Partnership, SAN, Pharmacy, School, Sale, Acquisition, Student, Trust, Silicon, Housing, Energy Star, Safety

SAN JOSE, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Affirmed Housing, a leading provider of affordable, multifamily housing throughout California, announces the completion of 79 homes at Vitalia, a new, affordable and supportive housing development located at 3100 S. Bascom Avenue in San Jose’s Cambrian neighborhood.

Key Points: 
  • SAN JOSE, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Affirmed Housing, a leading provider of affordable, multifamily housing throughout California, announces the completion of 79 homes at Vitalia, a new, affordable and supportive housing development located at 3100 S. Bascom Avenue in San Jose’s Cambrian neighborhood.
  • “Access to affordable housing is a significant step in the right direction toward ensuring that these individuals and many others have safe, stable options to call home.
  • That is why it is so critically important that we continue to invest robustly in affordable housing across this region.
  • “As a nonprofit financial intermediary, Housing Trust’s mission is to use public and private partnerships to create more equitable and affordable communities.

Guidehouse Honored with Don Strong Community Partner Award for 2024 by George Washington University Milken Institute School of Public Health

Retrieved on: 
Tuesday, April 9, 2024
Employment, Organization, Public health, Veterans' affairs, Partnership, George Washington University, Public, Knowledge, Food and Drug Administration, University, Human services, Doctor of Philosophy, MD, Student, Bangladesh Technical Education Board, National Institutes of Health, Veritas Capital, Public sector, Medicare, Milken Institute, SPH, Consultant, MHA, Food

WASHINGTON, April 9, 2024 /PRNewswire/ -- Guidehouse , a leading global provider of strategy and managed services to commercial and public sector clients, is proud to announce it has been chosen as the recipient of the Don Strong Community Partner Award for 2024 by the George Washington University Milken Institute School of Public Health (SPH).

Key Points: 
  • WASHINGTON, April 9, 2024 /PRNewswire/ -- Guidehouse , a leading global provider of strategy and managed services to commercial and public sector clients, is proud to announce it has been chosen as the recipient of the Don Strong Community Partner Award for 2024 by the George Washington University Milken Institute School of Public Health (SPH).
  • The Don Strong Community Partner Award is presented to organizations that demonstrate exceptional dedication to advancing public health initiatives and promoting the well-being of communities worldwide.
  • Guidehouse received this prestigious recognition in support of its partnership with the Milken Institute SPH, and steadfast support of the school's mission to educate and train future leaders in public health.
  • Guidehouse was celebrated at the Community Partner Appreciation Event on April 4 at the Milken Institute SPH.

UpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Thursday, March 21, 2024
Pro forma, Working capital, Bankruptcy, Growth, International court, Veterans' affairs, Mental, International, TTC, Patient, Mental health, Sale, Acquisition, Tribunal, Judgement, BHS, Commerce, Adjustment, OTC, Tax, De novo, Holding, GTCR, Video game

DELRAY BEACH, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“we,” “UpHealth,” or the “Company”) (OTC: UPHL) today provided a corporate update and announced financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • “In short, 2023 was a challenging, yet transformative, year for UpHealth, as we continued to take steps to stabilize the business,” said Martin Beck, Chief Executive Officer.
  • Growth in proforma revenues in the fourth quarter of 2023 was driven by top line growth at TTC Healthcare and Cloudbreak and by certain non-recurring revenues associated with the cessation of operations at Thrasys;
    Proforma fourth quarter 2023 gross margins were 62%, compared to 45% for the fourth quarter of 2022.
  • Proforma margin improvement in the fourth quarter was largely driven by an improved payor mix at TTC Healthcare;
    Proforma fourth quarter 2023 Adjusted EBITDA was $11.1 million, compared with $1.9 million in the fourth quarter of 2022.
  • TTC Healthcare’s performance in 2023, and in particular the fourth quarter 2023, was driven by strong volumes and a significantly improved payor mix.

UpHealth Completes Sale of Cloudbreak Health at $180 Million Full Cash Deal

Retrieved on: 
Monday, March 18, 2024
Working capital, IGI, Tax, Bed, Veterans' affairs, Patient, Religion, Sale, Investment, Annual report, GTCR

“This transaction is one more critical milestone in the last three years of UpHealth, Inc.’s journey to focus the Company on its strategic core and most profitable businesses.

Key Points: 
  • “This transaction is one more critical milestone in the last three years of UpHealth, Inc.’s journey to focus the Company on its strategic core and most profitable businesses.
  • The sale announced today of Cloudbreak, and the sale of IGI in May 2023 in a $56 million cash deal, have together generated to the Company about $235 million of cash that has allowed us to significantly reduce the liabilities of the Company and enhance its business focus and the financial performance, all resulting in unlocking meaningful value to our stakeholders.
  • “The Cloudbreak sale transaction will significantly deleverage our balance sheet, stabilize our business and empower us to concentrate our resources on TTC Healthcare,” said Martin Beck, Chief Executive Officer.
  • The proceeds of the Cloudbreak sale, after transaction-related fees and expenses, have been deposited into three escrow accounts: a Notes escrow ($139 million), a Tax escrow ($27 million) and a Working Capital escrow ($3 million).

Linear Health Sciences Publishes Whitepaper Examining IV Dislodgement

Retrieved on: 
Wednesday, March 27, 2024
Health, Medical Devices, Hospitals, General Health, Research, Science, Biotechnology, RN, SRV, Safety, Veterans' affairs, Orchid, Patient, Impact, Doctor of Philosophy, Outline of health sciences, Therapy, Brun Fourca, Medical device

Linear Health Sciences , a medical device company that has developed a proprietary, breakaway safety valve platform, today announced the publication of a new whitepaper on accidental dislodgement of IV catheter lines.

Key Points: 
  • Linear Health Sciences , a medical device company that has developed a proprietary, breakaway safety valve platform, today announced the publication of a new whitepaper on accidental dislodgement of IV catheter lines.
  • Clinical simulation testing of 360 Orchid SRVs showed that the device prevented IV dislodgement by 91.9 percent across all test groups.
  • The device is placed between the existing IV extension set and general IV tubing connection intended to be used for delivery of fluids to and from an IV catheter.
  • Additionally, Linear Health Sciences was awarded a Federal Supply Schedule with VA/Department of Defense access contract by the U.S. Dept.

Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion

Retrieved on: 
Monday, March 18, 2024
Pharmaceutical, Health, Neurology, Clinical Trials, Depression, Metabolism, Brain, NCE, Acute stress disorder, Concussion, Veterans' affairs, Executive, Common, Inflammation, Patient, United States Congress, TBI, Foundation (nonprofit), Anxiety, CTE, University, Military personnel, Oxidative stress, Human, GMP, Nasal cavity, Traumatic brain injury, DSM-IV codes, Phase, Traffic, Swelling, FDA, Animal, Pentagon, Chronic traumatic encephalopathy, Phase II, Marcus Foundation, Medical device

Oragenics’ lead drug candidate, ONP-002 is combined with its intranasal device intended for the treatment of mild Traumatic Brain Injury (TBI), aka concussion.

Key Points: 
  • Oragenics’ lead drug candidate, ONP-002 is combined with its intranasal device intended for the treatment of mild Traumatic Brain Injury (TBI), aka concussion.
  • Dr. Kelly was also National Director of the Avalon Action Alliance TBI Programs for which the MIBH serves as the clinical coordinating center.
  • “I am excited to join Oragenics as its Chief Medical Officer at such an important and pivotal time in the drug development process.
  • Dr. Kelly has interacted with the FDA and clinical trials for brain injury throughout his esteemed career.

AbilityOne: Creating and sustaining employment opportunities for people who are blind

Retrieved on: 
Monday, March 18, 2024
People with Disabilities, Medical Supplies, Human Resources, Thought Leadership, Communications, Professional Services, DEI (Diversity, Equity and Inclusion), Social Activism, Consumer, Health, Veterans' affairs, Employment, Government, Paratriathlon, Environment, Partnership, Javits–Wagner–O'Day Act, Ageing, Workforce, Disability, National Association, Senate, Work, Management

It leverages the procurement of needed goods and services for the government to create employment at a fair market price.

Key Points: 
  • It leverages the procurement of needed goods and services for the government to create employment at a fair market price.
  • The AbilityOne Program is meant to promote the employment of people who are blind or have severe disabilities; however, those who are blind are facing challenges to finding employment options.
  • All employees are offered opportunities for cross-training, upward mobility and provided assistance if they want to seek employment elsewhere.
  • I am asking you to advocate for a full range of choices of employment opportunities for people with disabilities.